State Street’s Lexaria Bioscience LEXX Stock Holding History

State Street’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22K	Hold	2,620	–	–	﹤0.01%	4128
2026 Q1	$30.7K	Hold	2,620	–	–	﹤0.01%	4182
2025 Q4	$24.2K	Hold	2,620	–	–	﹤0.01%	4230
2025 Q3	$37.4K	Hold	2,620	–	–	﹤0.01%	4186
2025 Q2	$34.2K	Hold	2,620	–	–	﹤0.01%	4147
2025 Q1	$67.2K	Hold	2,620	–	–	﹤0.01%	4046
2024 Q4	$82.5K	Hold	2,620	–	–	﹤0.01%	4029
2024 Q3	$120K	Hold	2,620	–	–	﹤0.01%	3940
2024 Q2	$109K	Hold	2,620	–	–	﹤0.01%	3988
2024 Q1	$143K	Buy	+2,620	New	+$100K	﹤0.01%	3951

Other funds holding LEXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

CBT

Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

State Street's LEXX Position: Q2 2026 in Review

State Street held its Lexaria Bioscience (LEXX) position steady in Q2 2026 at 2,620 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #4128.

State Street first reported a position in LEXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $143K in Q1 2024. 6 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

State Street held 2,620 shares of Lexaria Bioscience worth $22K as of Q2 2026.
State Street left its Lexaria Bioscience share count unchanged in Q2 2026.
Lexaria Bioscience made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4128 holding.
State Street first reported a position in Lexaria Bioscience in Q1 2024 and has held it in 10 quarters since.
State Street's Lexaria Bioscience position peaked at $143K in Q1 2024.
6 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.